(Q36020276)

11 August 2017

1 reference

MDMA

0 references

title

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (English)

1 reference

11 August 2017

Parrott AC

1

1 reference

PubMed ID

15671132

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of Psychopharmacology

11 August 2017

1 reference

11 August 2017

19

1 reference

11 August 2017

1

1 reference

11 August 2017

71-83

1 reference

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Memory impairment in abstinent MDMA ("Ecstasy") users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The content of ecstasy tablets: implications for the study of their long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Altered states: the clinical effects of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Auditory verbal learning in drug-free Ecstasy polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

'Weddings, parties, anythingellipsis', a qualitative analysis of ecstasy use in Perth, Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy (MDMA) dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy and neurodegeneration. Advice is that "less is more".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Endogenous 5‐HT, released by MDMA through serotonin transporter‐ and secretory vesicle‐dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5‐HT1B receptors located on CA1 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Specific neurotoxicity of chronic use of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA and the loss of reinforcement in Fantegrossi et al (2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Ecstasy and new patterns of drug use: a normal population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA on the Street: Analysis Anonymous®

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

The background and chemistry of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Monitoring synthetic drug markets, trends, and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Interactions of amphetamine analogs with human liver CYP2D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048900

21 January 2018

Identifiers

DOI

10.1177/0269881105048900

1 reference

11 August 2017

1 reference

PubMed ID

15671132